Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00575081 · ClinicalTrials.gov registry record
Physiological Brain Atlas Development
A clinical trial of Epilepsy and Parkinson's Disease, sponsored by Vanderbilt University Medical Center.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT00575081: Recruiting study of Epilepsy and Parkinson's Disease, sponsored by Vanderbilt University Medical Center.
NCT00575081 is a study of Epilepsy and Parkinson's Disease that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 5,000 participants, above the 921-participant average among 160 other Epilepsy trials with a reported enrollment target (443% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00575081, a study of Epilepsy and Parkinson's Disease, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The NIH grant has funded the development of a physiological brain atlas registry that will allow us to significantly improve the data collectioin and use of physiological data into a normalized brain volume. This initially was used to improve DBS implants for Parkinson's Disease, Dystonia, Essential Tremor, and OCD, but now includes data acquired during all stereotactic brain procedures.
Primary Outcome
The above data will specifically be acquired from the population of patients undergoing Stereotactic Brain Surgery
Conditions Studied
Interventions
- DEVICE Stereotactic brain procedures
Study Locations (1)
Tennessee
- Vanderbilt Univeristy - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2006-08 |
| Est. Completion | 2026-08 |
What NCT00575081 shows while recruiting
NCT00575081 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 921-participant average among 160 other Epilepsy trials with a reported enrollment target (443% higher).
The record links to 5 conditions, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Stereotactic brain procedures is the first listed.
NCT00575081 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT00575081 about?
NCT00575081 is a clinical study titled "Physiological Brain Atlas Development". The NIH grant has funded the development of a physiological brain atlas registry that will allow us to significantly improve the data collectioin and use of physiological data into a normalized brain volume. This initially was used to improve DBS implants for Parkinson's Disease, Dystonia, Essential...
What is the current status of trial NCT00575081?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2006-08. Estimated completion is 2026-08.
What conditions does trial NCT00575081 study?
This clinical trial studies the following conditions: Epilepsy, Parkinson's Disease, Obsessive - Compulsive Disorder, Essential Tremor, Dystonia.
What interventions are being tested in trial NCT00575081?
The interventions under investigation include: Stereotactic brain procedures (DEVICE).
Who is sponsoring clinical trial NCT00575081?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00575081 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00575081's enrollment target sits among peer trials
5,000 3rd of 160 higher than 157 of 160 other Epilepsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Epilepsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
RECRUITING
-
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
RECRUITING
-
SeizEAR Safety Study
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Tumor Related Epilepsy
RECRUITING
-
Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
- NCT00991094 · 5,000 participants
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia